Limited effectiveness of elexacaftor-tezacaftor-ivacaftor on lung hyperinflation in adults with cystic fibrosis

被引：0
|
作者：
Dhote, Theo [1 ]
Martin, Clemence [1 ]
Regard, Lucile [1 ]
Kanaan, Reem [1 ]
Carlier, Nicolas [1 ]
Honore, Isabelle [1 ]
Fesenbeckh, Johanna [1 ]
Burnet, Esperie [1 ]
Fajac, Isabelle [2 ]
Aubourg, Frederique [2 ]
Perez, Thierry [3 ]
Da Silva, Jennifer [1 ]
Burgel, Pierre-Regis [1 ]
机构：
[1] Cochin Hosp, Assistance Publ Hop Paris, Natl Reference Cyst Fibrosis Ctr, Dept Resp Med, Paris, France
[2] Cochin Hosp, Assistance Publ Hop Paris, Dept Physiol, Paris, France
[3] CHRU Lille, Albert Calmette Hosp, Dept Resp Med, Lille, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.OA2906
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Severity of lung function impairment change in people with cystic fibrosis after access to Elexacaftor-Tezacaftor-ivacaftor
    Smith, Iain
    Wood, Michelle
    Cobb, Robyn
    McMahon, Tracy
    Lacey, Andrea
    Masel, Philip
    Reid, David
    Smith, Daniel
    RESPIROLOGY, 2024, 29 : 37 - 38
  • [32] INITIATION OF ELEXACAFTOR-TEZACAFTOR-IVACAFTOR LEADING TO LUNG TRANSPLANTATION
    Homan, Travis
    Link, Stephanie
    Barrios, Christopher
    CHEST, 2020, 158 (04) : 1367A - 1367A
  • [33] Patient perspectives following initiation of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis and advanced lung disease
    Martin, C.
    Burnet, E.
    Ronayette-Preira, A.
    de Carl, P.
    Martin, J.
    Delmas, L.
    Prieur, B.
    Burgel, P. -R.
    RESPIRATORY MEDICINE AND RESEARCH, 2021, 80
  • [34] Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor
    Reasoner, Seth A.
    Bernard, Rachel
    Waalkes, Adam
    Penewit, Kelsi
    Lewis, Janessa
    Sokolow, Andrew G.
    Brown, Rebekah F.
    Edwards, Kathryn M.
    Salipante, Stephen J.
    Hadjifrangiskou, Maria
    Nicholson, Maribeth R.
    MBIO, 2024, 15 (02):
  • [35] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
  • [36] Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor
    Patel, Payal
    Yeley, Jana
    Brown, Cynthia
    Wesson, Melissa
    Lesko, Barbara G.
    Slaven, James E.
    Chmiel, James F.
    Jain, Raksha
    Sanders, Don B.
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2023, 9 (01)
  • [37] Characterization of sleep in emerging adults with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor
    Meltzer, Lisa J.
    Gross, Jane E.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (01) : 132 - 136
  • [38] Effect of 18 months elexacaftor-tezacaftor-ivacaftor on body mass index and glycemic control in adults with cystic fibrosis
    Taelman, Valerie
    Declercq, Dimitri
    Van Biervliet, Stephanie
    Vande Weygaerde, Yannick
    Lapauw, Bruno
    Van Braeckel, Eva
    CLINICAL NUTRITION ESPEN, 2023, 58 : 73 - 78
  • [39] Depression and Anxiety in Patients with Cystic Fibrosis after Six Months on Elexacaftor-Tezacaftor-Ivacaftor
    Dell, Mary
    May, Anne
    Pasley, Kimberly E.
    Johnson, Marci
    Sliemers, Stephanie
    Nemastil, Christopher J.
    Bai, Shasha
    Eisner, Mariah
    Stephan, Emily A.
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2022, 63 : S119 - S120
  • [40] Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
    Middleton, P. G.
    Mall, M. A.
    Drevinek, P.
    Lands, L. C.
    McKone, E. F.
    Polineni, D.
    Ramsey, B. W.
    Taylor-Cousar, J. L.
    Tullis, E.
    Vermeulen, F.
    Marigowda, G.
    Mckee, C. M.
    Moskowitz, S. M.
    Nair, N.
    Savage, J.
    Simard, C.
    Tian, S.
    Waltz, D.
    Xuan, F.
    Rowe, S. M.
    Jain, R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (19): : 1809 - 1819
12345